HIV-1 Rev (34-50)

CAS No. 141237-50-5

HIV-1 Rev (34-50) ( —— )

Catalog No. M29575 CAS No. 141237-50-5

HIV-1 Rev (34-50) is a 17 amino acid peptide with anti-HIV-1 activity. HIV-1 Rev (34-50) is derived from the Rev-responsive element-binding domains of Rev in HIV-1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 447 Get Quote
10MG 651 Get Quote
25MG 1017 Get Quote
50MG 1368 Get Quote
100MG 1782 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HIV-1 Rev (34-50)
  • Note
    Research use only, not for human use.
  • Brief Description
    HIV-1 Rev (34-50) is a 17 amino acid peptide with anti-HIV-1 activity. HIV-1 Rev (34-50) is derived from the Rev-responsive element-binding domains of Rev in HIV-1.
  • Description
    HIV-1 Rev (34-50) is a 17 amino acid peptide with anti-HIV-1 activity. HIV-1 Rev (34-50) is derived from the Rev-responsive element-binding domains of Rev in HIV-1.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    141237-50-5
  • Formula Weight
    2437.7
  • Molecular Formula
    C97H173N51O24
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC(NCCC[C@H](NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](C)NC([C@H](CCC(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H]([C@@H](C)O)N)=O)=O)=O)=O)=O)=O)CC(N)=O)=O)=O)C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC2=CC=CC=C21)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)CCCNC(N)=N)=O)=N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HIV-1 inhibitor 18A

    HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.

  • Zalcitabine

    A pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS.

  • Raltegravir potassiu...

    A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.